Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-18

Clinical Trial Update: Evaluation of ACUVUE OASYS® 1-Day for Astigmatism Lenses Produced on a New Manufacturing Line [NA]

View source ↗

Summary

Clinical trial update on ACUVUE OASYS 1-Day for Astigmatism lenses produced on a new manufacturing line; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACUVUE OASYS 1-Day for Astigmatism (etafilcon A contact lenses with perfluorinated acrylic ester surface treatment (acuvue oasys 1-day for astigmatism) )

Snippet

Sponsor: Johnson & Johnson Vision Care, Inc. | Conditions: Visual Acuity | NA | Status: COMPLETED | Results posted: 2022-05-18